Paper
RSC Advances
(Fig. 6), Raman analysis (Fig. 7), CO2-TPD (Fig. 8), magnetic
studies (Fig. 9), nitrogen BET adsorption–desorption pattern
(Fig. 10), and TGA-DTA-DTG pattern (Fig. 11).
3.3.3. 4-(3-Benzylimidazo[1,2-a]pyridin-2-yl)phenol
(4c).
Compound (4c) was prepared in 84% yield from 2-amino-
pyridine (1 mmol) (1a), 4-hydroylbenzaldehyde (1 mmol) (2c),
and phenyl acetylene (1 mmol) (3); white solid; M.P.: 137–
139 ꢀC; IR (ATR, n, cmꢁ1): 3449 (O–H), 2989 (C–Hasym, sp3), 2880
(C–Hsym, sp3), 1634 (C]C/C]N), 1613, 1482, 1453 (C/C ring
3.3. General procedure for the ultrasonic-assisted synthesis
of imidazo[1,2-a]pyridines derivatives (4a–j)
1
str.), 1087 (C–O); H NMR (400 MHz, CDCl3): dH ppm 4.52 (s,
A mixture of 2-aminopyridine derivatives (1 mmol) (1a–b),
pertinent aryl aldehyde (1 mmol) (2a–e), phenyl acetylene (1
mmol) (3) and a catalytic amount (7 mol% or 0.07 g) of CoFe2O4-
HMS in PEG 400 (5 mL) was irradiated employing an ultra-
sonicator at room temperature for the optimal time (25–40
min). Considering that the reaction time was very short, there
was no substantial increase in temperature due to ultrasonic
shock. The ultrasonic apparatus used showed the temperature
automatically, and thus the temperature was controlled and
xed at room temperature using a water circulator in the case of
any temperature increase.20 The progress of the reaction was
monitored through TLC (on aluminum sheets precoated with
silica) using n-hexane/ethyl acetate (4 : 1) as the eluting system.
Aer the reaction was complete, the mixture was diluted with
ethyl acetate (2 mL). The organic layer was washed with water
and dried over MgSO4 and concentrated under vacuum. The
catalyst was separated via a magnetic bar to obtain pure prod-
ucts (4a–j) (Table 2).25
2H), 6.28 (s, 1H), 6.92–6.95 (m, 1H), 7.07–7.12 (m, 2H), 7.17–7.21
(m, 2H), 7.23–7.26 (m, 1H), 7.27–7.30 (m, 3H), 7.31–7.38 (m,
2H), 7.69–7.73 (m, 2H); 13C NMR (100 MHz, CDCl3): d 29.9 (C-
16), 112.5 (C-9), 116.5 (C-12, 14), 117.4 (C-7), 117.8 (C-6), 123.6
(C-8), 125.5 (C-10), 127.1 (C-20), 127.2 (C-5), 129.1 (C-19, 21),
129.3 (C-11, 15), 130.0 (C-18, 22), 136.8 (C-17), 144.1 (C-4), 144.8
(C-2), 158.6 (C-13); HRMS (ESI) m/z: 300.1256 [M + H]+; Anal.
Cald. for C20H16N2O: C, 79.98; H, 5.37; N, 9.33%. Found C,
80.02; H, 5.41; N, 9.38%.
3.3.4. 3-Benzyl-2-(2-nitrophenyl)imidazo[1,2-a]pyridine
(4d). Compound (4d) was prepared in 82% yield from 2-ami-
nopyridine (1 mmol) (1a), 2-nitrobenzaldehyde (1 mmol) (2d),
and ꢀphenyl acetylene (1 mmol) (3); white solid; M.P.: 166–
167 C; IR (ATR, n, cmꢁ1): 2948 (C–Hasym, sp3), 2916 (C–Hsym
,
sp3), 1634 (C]C/C]N), 1543 (N–O), 1611, 1481, 1453 (C/C
ring str.); 1H NMR (400 MHz, CDCl3): dH ppm 4.51 (s, 2H, CH2),
6.91–6.93 (m, 1H), 7.16–7.19 (m, 2H), 7.21–7.24 (m, 1H), 7.27–
7.31 (m, 3H), 7.67–7.71 (m, 2H), 7.78–7.81 (m, 1H), 7.93–7.96
(m, 1H), 8.08–8.11 (m, 2H); 13C NMR (100 MHz, CDCl3): d 29.9
(C-16), 112.6 (C-9), 117.4 (C-7), 117.8 (C-6), 123.6 (C-8), 124.5 (C-
12), 124.9 (C-5), 125.3 (C-10), 127.1 (C-20), 128.5 (C-19, 21), 128.9
(C-18, 22), 129.7 (C-13), 132.7 (C-15), 135.4 (C-14), 136.8 (C-17),
144.2 (C-4), 144.9 (C-2), 148.9 (C-11); HRMS (ESI) m/z:
329.1156 [M + H]+; Anal. Cald. for C20H15N3O2: C, 72.94; H,
4.59; N, 12.76%. Found: C, 72.97; H, 4.62; N, 12.79%.
The analytical and spectroscopic data for the synthesized
imidazo[1,2-a]pyridines derivatives (4a–j) are given below:
3.3.1. 3-Benzyl-2-phenylimidazo[1,2-a]pyridine
(4a).
Compound (4a) was prepared in 89% yield from 2-amino-
pydrine (1 mmol) (1a), benzaldehyde (1 mmol) (2a), phenyl-
ꢀ
acetylene (1 mmol) (3); white solid; M.P.: 121–122 C; IR (ATR,
n, cmꢁ1): 2942 (C–Hasym, sp3), 2872 (C–Hsym, sp3), 1637 (C]C/
C]N), 1611, 1480, 1434 (C/C ring str.); 1H NMR (400 MHz,
CDCl3): dH ppm 4.53 (s, 2H, CH2), 6.92–6.96 (m, 1H), 7.17–7.22
(m, 2H), 7.23–7.26 (m, 1H), 7.29–7.40 (m, 4H), 7.43–7.48 (m,
2H), 7.70–7.73 (m, 2H), 7.80–7.83 (m, 2H); 13C NMR (100 MHz,
CDCl3): d 29.9 (C-16), 112.5 (C-9), 117.5 (C-7), 117.8 (C-6), 123.5
(C-8), 124.6 (C-5), 127.0 (C-13, 20), 127.8 (C-11, 15), 128.4 (C-19,
21), 128.8 (C-18, 22), 129.2 (C-12, 14), 134.3 (C-10), 136.8 (C-17),
144.0 (C-4), 145.0 (C-2); HRMS (ESI) m/z: 284.1306 [M + H]+;
Anal. Cald. for C20H16N2: C, 84.48; H, 5.67; N, 9.85%. Found: C,
84.49; H, 5.69; N, 9.89%.
3.3.5. 4-(3-Benzylimidazo[1,2-a]pyridin-2-yl)-3-
methoxyphenol (4e). Compound (4e) was prepared in 78% yield
from 2-amino pyridine (1 mmol) (1a), 4-hydroxy-2-
methoxybenzaldehyde (1 mmol) (2e), and phenyl acetylene (1
mmol) (3); white solid; M.P.: 164–165 ꢀC; IR (ATR, n, cmꢁ1): 3470
(O–H), 2942 (C–Hasym, sp3), 2912 (C–Hsym, sp3), 1636 (C]C/C]
N), 1613, 1483, 1439 (C/C ring str.), 1287, 1082 (C–O); 1H NMR
(400 MHz, CDCl3): dH ppm 3.94 (s, 3H, OCH3), 4.53 (s, 2H, CH2),
6.30–6.74 (s, 2H), 6.96–6.99 (m, 1H), 7.07–7.11 (m, 1H), 7.17–
7.20 (m, 2H), 7.21–7.23 (m, 1H), 7.25–7.34 (m, 3H), 7.38–7.41
(m, 2H), 7.71–7.74 (m, 1H); 13C NMR (100 MHz, CDCl3): d 29.9
(C-16), 56.1 (C-110), 106.2 (C-12), 108.8 (C-14), 112.6 (C-9), 115.6
(C-10), 117.4 (C-7), 117.9 (C-6), 124.3 (C-8), 126.0 (C-20), 127.8
(C-5), 129.1 (C-19, 21), 130.1 (C-18, 22), 132.0 (C-15), 137.0 (C-
17), 144.1 (C-4), 144.8 (C-2), 154.8 (C-13), 158.7 (C-11); HRMS
(ESI) m/z: 330.1354 [M + H]+; Anal. Cald. for C21H18N2O2: C,
76.34; H, 5.49; N, 8.48%. Found C, 76.37; H, 5.51; N, 8.52%.
3.3.6. 3-Benzyl-7-methyl-2-phenylimidazo[1,2-a]pyridine
(4f). Compound (4f) was prepared in 91% yield from 2-amino-4-
methyl pyridine (1 mmol) (1b), benzaldehyde (1 mmol) (2a), and
phenyl acetylene (1 mmol) (3); white solid; M.P.: 160–162 ꢀC; IR
(ATR, n, cmꢁ1): 2956 (C–Hasym, sp3), 2928 (C–Hsym, sp3), 1634
3.3.2. 3-Benzyl-2-(4-chlorophenyl)imidazo[1,2-a]pyridine
(4b). Compound (4b) was prepared in 86% yield from 2-ami-
nopyridine(1 mmol) (1a), 4-chlorobenzaldehyde (1 mmol) (2b),
phenylacetylene (1 mmol) (3); white solid; M.P.: 144–145 ꢀC; IR
(ATR, n, cmꢁ1): 2953 (C–Hasym, sp3), 2928 (C–Hsym, sp3), 1634
1
(C]C/C]N), 1613, 1481, 1436 (C/C ring str.), 698 (C–Cl); H
NMR (400 MHz, CDCl3): dH ppm 4.58 (s, 2H, CH2), 6.91–6.94 (m,
1H), 7.16–7.21 (m, 2H), 7.22–7.26 (m, 1H), 7.27–7.29 (m, 3H),
7.30–7.38 (m, 2H), 7.69–7.73 (m, 4H); 13C NMR (100 MHz,
CDCl3): d 29.9 (C-16), 112.5 (C-9), 117.4 (C-7), 117.6 (C-6), 123.5
(C-8), 127.2 (C-20), 127.2 (C-5), 128.6 (C-19, 21), 129.1 (C-11, 15),
129.2 (C-18, 22), 129.5 (C-12, 14), 129.8 (C-10), 134.4 (C-13),
136.6 (C-17), 144.0 (C-4), 144.8 (C-2); HRMS (ESI) m/z:
318.0915 [M + H]+; Anal. Cald. for C20H15ClN2: C, 75.35; H,
4.74; N, 8.79%. Found: C, 75.38; H, 4.77; N, 8.82%.
1
(C]C/C]N), 1612, 1487, 1449 (C/C ring str.); H NMR (400
MHz, CDCl3): dH ppm 2.47 (s, 3H, CH3), 4.57 (s, 2H, CH2), 7.16–
© 2021 The Author(s). Published by the Royal Society of Chemistry
RSC Adv., 2021, 11, 23207–23220 | 23217